Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK19 inhibitors(Cyclin-dependent kinase 19 inhibitors), CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H22ClN7O |
InChIKeyYLJSAFSDGFNKAC-UHFFFAOYSA-N |
CAS Registry2648453-53-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 26 Nov 2019 | |
Neurodegenerative Diseases | Preclinical | United States | 26 Nov 2019 |